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Abstract
Pathogenic Yersinia species possess a type III secretion system, which is required for the delivery of effector Yop proteins
into target cells during infection. Genes encoding the type III secretion machinery, its substrates, and several regulatory
proteins all reside on a 70-Kb virulence plasmid. Genes encoded in the chromosome of yersiniae are thought to play
important roles in bacterial perception of host environments and in the coordinated activation of the type III secretion
pathway. Here, we investigate the contribution of chromosomal genes to the complex regulatory process controlling type
III secretion in Yersinia pestis. Using transposon mutagenesis, we identified five chromosomal genes required for expression
or secretion of Yops in laboratory media. Four out of the five chromosomal mutants were defective to various extents at
injecting Yops into tissue culture cells. Interestingly, we found one mutant that was not able to secrete in vitro but was fully
competent for injecting Yops into host cells, suggesting independent mechanisms for activation of the secretion apparatus.
When tested in a mouse model of plague disease, three mutants were avirulent, whereas two strains were severely
attenuated. Together these results demonstrate the importance of Y. pestis chromosomal genes in the proper function of
type III secretion and in the pathogenesis of plague.
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Introduction
Yersinia pestis, the causative agent of plague, is one of three
Yersinia species pathogenic to humans. All three species share a
tropism for lymphoid tissues and utilize a type III secretion system
(TTSS) to undermine the host immune system [1,2]. The Yersinia
TTSS is encoded by a conserved 70-kb virulence plasmid, termed
pCD1 in Y. pestis [3]#. In addition to the machinery components
and its secreted substrates (YopB, YopD, YopE, YopH, YopM,
YopN, YopO, YopP, YopK, YopR, YopT, LcrV, and LcrQ),
pCD1 encodes several regulatory proteins that respond to
environmental cues. Expression of the TTSS and its substrates
are induced upon temperature shift to 37uC by the transcriptional
activator LcrF [4,5,6,7]. YopD, LcrH, and YscM1/YscM2 (LcrQ)
repress activation of the TTSS in the absence of certain serum
amino acids [8]#. YopN, TyeA, SycN, YscB and LcrG prevent
transport of Yop effectors until contact with a target cell is made
[9,10,11,12,13,14,15,16,17,18]. These conditions can be simulat-
ed in vitro, and upon a shift to 37uC in the absence of calcium,
yersiniae undergo growth cessation and massively secrete all of the
type III substrates into the medium [19,20,21,22,23]. This
phenomenon is referred to as the LCR (low calcium response)
phenotype [24]#. The onset of bacteriostasis under TTSS-
inducing conditions is particularly severe for Y. pestis compared
to the enteric Yersinia and correlates with a loss of aspartase and
glucose-6-phosphate dehydrogenase functions [19,25,26,27]. In-
terestingly, calcium does not prevent growth or Yop expression
during cell culture, and indeed bacteriostasis can be uncoupled
from induction of the Yersinia TTSS by manipulating levels of
glutamate, sodium, and pH to reflect the presumed in vivo
conditions of a necrotic lesion [19,28,29,30]. Therefore while the
calcium-dependent LCR phenotype may be an artifact of in vitro
culture conditions, this Yersinia-specific phenomenon has been
utilized as a tool to investigate the details of TTSS regulation and
function in Yersinia. It has been suggested that yersiniae sense
environmental calcium concentrations in the extracellular fluids of
their host and in the cytoplasm of host cells via insertion of the
type III secretion needle into the plasma membrane of target host
cells [16,31,32]; however the mechanism for sensing calcium levels
remains a mystery.
Although many of the genes required for activation of the type
III pathway in response to environmental signals have been
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environment and contact with a target cell and then transmit that
information to the cytoplasm and secretion apparatus remains
unclear. Also, early work in Y. enterocolitica suggested that the
virulence plasmid is necessary, but not sufficient, for expression
and/or delivery of effector Yops [33,34]#. Presumably, additional
unidentified genes are involved in the regulation of type III
secretion. In 1984, Goguen and colleagues performed a genetic
analysis, taking advantage of the LCR growth phenotype that
occurs at 37uC in the absence of calcium, and reported that a large
number of Y. pestis mutations, which seemed to be chromosomally
located, gave rise to an LCR
2 phenotype [24]. However, these
mutants remain uncharacterized.
In an effort to determine the potential role of chromosomal
genes in the regulation of the Yersinia TTSS, we undertook a screen
similar to that of Goguen et al. Using a Mu transposon derivative
[35], we generated insertional mutations in Y. pestis and isolated
mutants with an LCR
2 phenotype, i.e. the variants gained the
ability to grow at elevated temperatures in the absence of calcium.
These mutants were then evaluated for their ability to secrete Yops
when grown in calcium-depleted medium. The location of the
transposon insertion was determined for each secretion-defective
mutant based on inverse PCR and sequence analysis. After
screening 2067 mutants displaying the LCR
2 growth phenotype,
we identified 5 variants (termed CHI strains for chromosomal
insertion) harboring a transposon insertion that gave rise to defects
in secretion of Yops and/or expression of the TTSS. The ability of
the 5 strains to target Yops into host cells during tissue culture
infection was also analyzed, revealing a distinction between a
secretion defect and a targeting defect in some cases. Further
characterization of the mutants in a mouse model of infection
confirmed the importance of the identified genes in virulence.
Materials and Methods
Bacterial strains and media
All Yersinia pestis strains are attenuated (non-pigmented) variants
of Y. pestis biovar mediaevalis KIM lacking the 102-kb pgm locus
[36]. KIM5 (pCD1+, pMT1+, pPCP1+) was obtained from R.
Brubaker. KIM8 (pCD1+, pMT1+, pPCP12) and YP769 (also
called KIM8 D1234 [37]; pMT1+, pPCP12, pCD1+ DyopM/
yopT/sycT/yopK/ylpA/yopE/sycE/ypkA/yopJ/yopH) were obtained
from G. Plano. Y. pestis strains were propagated on Heart Infusion
or Blood Base agar plates at 26uC for two days. Overnight cultures
were grown in Heart Infusion Broth (HIB) at 26uC. Antibiotics
were added as appropriate to a final concentration of 20 mg/ml
chloramphenicol, 50 mg/ml ampicillin, or 50 mg/ml kanamycin.
Escherichia coli strains were propagated in LB broth or agar,
supplemented with 20 mg/ml chloramphenicol, 100 mg/ml ampi-
cillin, or 25 mg/ml kanamycin, at 37uC, except CR202, which was
grown at 30uC.
Mu Mutagenesis
E. coli CR202 carries the Mucts62pAp5hP1#1 lysogen (also
called MuAphP1), a Mu-P1 hybrid [35]#. To obtain a lysate,
overnight cultures of CR202 were subcultured 1:50 into HIB,
supplemented with 2.5 mM MgCl2 and 2.5 mM CaCl2, and
incubated at 30uC for 1 hour 45 minutes. The culture was then
shifted to 42uC for 2 hours, or until lysis occurred. The lysed
culture was sterilized by passing through a 0.2 mm filter and then
stored on ice until needed. Y. pestis KIM5 overnight cultures were
diluted 1:25 into the same medium and incubated at 26uC until
late exponential phase, about 3 hours. Cells were sedimented by
centrifugation and suspended in 10 mM MgSO4, followed by
incubation at room temperature for 20 minutes. To infect, 5 ml of
lysate was added to 2.5 ml of cells and incubated at room
temperature for 20 minutes. The cells were again sedimented by
centrifugation, suspended in 10 mM MgSO4, and plated on Blood
Base agar containing 20 mM sodium oxalate, 20 mM MgCl2 (BB/
MgOx agar), and 50 mg/ml ampicillin to select for Mu insertions
leading to an LCR
2 phenotype. During initial testing, the plates
were incubated at a range of temperatures (26uC, 30uC, 33uC,
35uC, and 37uC) for 2 days. At temperatures above 33uC, many
chromosomal insertion mutants also carried additional Mu
insertions on pCD1. We therefore chose 33uC for routine selection
of LCR
2 mutants.
Identification of mutants
Primer sequences are listed in Table S1. To determine the
location of the Mu insertion, chromosomal DNA of mutants was
digested with either Taq
a I or BspHI, followed by large-volume
ligation. Ligations were purified and used as the template for
inverse-PCR reactions using primers complimentary to the left
(BfaI-LT, BfaI-RT) and right (TaqI-LT, TaqI-RT) ends of Mu.
PCR products were sequenced using nested primers. The obtained
sequences were subjected to the following computational analysis.
Sequences were formatted into FASTA format, using only the
transposon sequence plus the following 160 nucleotides. If no
transposon sequence was found, the first 260 nucleotides were
used. These formatted sequences were then used to search the Y.
pestis KIM genome using the BLAST algorithm [38]. Positions of
significant BLAST hits against the genome were obtained from the
BLAST output and the genes surrounding or overlapping these
positions were recorded. Significant hits were those with an e-
value below 10
27 and percent identity over 30. Functional
characterization of disrupted genes was carried out using
bioinformatic analysis [39,40,41].
Complementation of mutants
False positive mutants were eliminated by pCD1 displacement.
Y. pestis KIM-3001.P39 carries a tagged pCD1 (referred to here as
pCD1::KM) in which the yopE-sycE locus was replaced by a
kanamycin resistance cassette [42]. Plasmid DNA isolated from
KIM-3001.P39 was electroporated into each chromosomal
mutant. Transformants were plated on BB containing kanamycin
to select for the tagged pCD1 (pCD1::KM). Displacement of the
original pCD1 by pCD1::KM was confirmed by immunoblotting
to demonstrate the loss of yopE and the presence of npt. Mutants
carrying pCD1::KM were screened by secretion assay and
immunoblotting (described below). Mutants retaining the secretion
defect were then subjected to gene-specific complementation.
Table S1 lists the primers and vectors used to clone and introduce
the wild-type gene or operon of interest into each mutant. The
PCR products for y0447 and rfaL were cloned into the pDONR-
221 vector using the BP Clonase mix as per manufacturer’s
instructions (Invitrogen) and then transformed into DH5a. The
pgsA locus was amplified with the pgsAORFNdeI pgsAORF-
BamHI primers to clone the open reading frame as an NdeI-
BamHI fragment. The native promoter was amplified using the
uvrYproEcoRI and uvrYproNdeI primers. The EcoRI-NdeI
promoter fragment and NdeI-BamHI ORF fragment were cloned
into the EcoRI-BamHI site of pHSG576 [43] by three-way
ligation. The regions containing folD and pssA were amplified using
the folD.SOE.3, folD.SOE.BamHI.4, pssA.SOE.3, and pssA.-
SOE.revEcoRI primers. The promoter region encompassing
,300 bp upstream of nptII was amplified using the npt.pro.-
SOE.PstI. and npt.pro.folD.SOE.2 or npt.pro.pssA.SOE.2 primer
pair. The npt promoter product and folD and pssA products were
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the pssA.SOE.3 and pssA.SOE.revEcoRI primer pair. The
resulting PCR products were cloned into the SmaI site of
pBluescript SK+ and sequenced. The Pnpt-folD and Pnpt-pssA
products were then cloned into the PstI and BamHI or PstI and
EcoRI sites of pHSG576. The resulting plasmids were named
pAH191 and pAH195. All constructs were introduced into their
respective CHI strains by electroporation.
Standard Secretion Assays
For routine screening, overnight cultures of Y. pestis strains were
diluted 1:40 into modified M9 (MM9) and secretion assays were
performed as previously described [44]. Briefly, cells were grown
at 26uC for 2 hours and then at 37uC for 3 hours. The OD600 of
each culture was taken following the incubation at 37uC. Cells
were sedimented and proteins in the pellet and supernatant
fractions were TCA precipitated and visualized by immunoblot-
ting. Samples were loaded onto SDS-PAGE gels based on the
OD600 of each culture compared to wild type unless noted
otherwise. Additional characterization of secretion phenotypes
were conducted by diluting overnight cultures into either HIB,
supplemented with 5 mM CaCl2 or 5 mM EGTA, or DMEM
tissue culture medium (see below) with or without supplemented
5 mM EGTA.
Flow cytometry to measure Bla reporter injection
Plasmids expressing YopM-Bla (pMM83), Gst-Bla (pMM91),
and YopE-Bla (pMM85) from their native promoters have been
previously described [44]. pAH83 was created to drive constitutive
expression of YopM-Bla. The regions containing yopM and bla
were amplified from pCD1 and pMM83, respectively, using the
npt.pro.yopM.SOE.3 and yopM.SOE.4.bla.2 or yopM.SOE.4.-
bla.2 and bla.SOE.4.EcoRI primer pair. The nptII promoter was
amplified using the npt.pro.SOE.BamHI.1 and npt.pro.yopM.-
SOE.2 primers. The resulting yopM, bla, and npt promoter
products were stitched together with Phusion using the primers
npt.pro.SOE.BamHI.1 and bla.SOE.4.EcoRI. The resulting PCR
product was cloned into the SmaI site of pBluescript SK+. The
Pnpt-yopM-bla region was then subcloned into the BamHI and
EcoRI sites of pHSG576, creating pAH83. All plasmids were
introduced into Y. pestis strains by electroporation. The night
before the experiment, 3.25610
5 CHO (ATCC, CCL-61) cells per
well were seeded into a 12 well plate and maintained in F12K
supplemented with 10% FBS at 37uC+5% CO2. Y. pestis strains
were grown to mid-exponential phase at 26uC in HIB with
chloramphenicol and then pre-induced at 37uC for 1.5 hrs. CHO
cells were counted and bacteria were added at an MOI of 10,
followed by centrifugation at 5006g for 5 min to facilitate cell
contact. The infections were incubated at 37uC for 3 hrs after
which the cells were washed with PBS and trypsin was added to
remove CHO cells from the plate. The trypsin was quenched with
the addition of 1 ml of F12K+10% FBS, cells were pelleted at
5006g for 5 min, and the cell pellets resuspended in 300 mLo f
HBSS-Flow (16Hank’s Buffered Saline Solution, 0.5 mM EDTA,
25 mM HEPES, 2% BSA, pH 7.4). 50 mLo f2 6 CCF-
2AM+probenicid was added to the cells, and the cells were
incubated at room temp for 15 min. Following the incubation,
300 mL of HBSS-Flow was added to each tube, and the cells were
analyzed on a BD LSRII flow cytometer to quantitate blue and
green fluorescence as previously described [44,45]. Significance
was determined using one-way ANOVA with a Tukey post-test in
GraphPad Prism 5.
Cytotoxicity Assays
The night before the infection, 2.5610
4 HeLa cells were seeded
into 12 well plates and maintained in DMEM supplemented with
GlutaMAX and 10% FBS at 37uC+5% CO2. Y. pestis strains were
grown to mid-exponential phase at 26uC in HIB with ampicillin
and then pre-induced at 37uC for one hour. The HeLa cells were
washed twice with 16PBS and counted. The media was replaced
with 1 mL of warm DMEM+10% FBS and GlutaMAX
containing bacteria at an MOI of 10, followed by centrifugation
at 5006g for 5 min to facilitate cell contact. After a 30 minute
incubation at 37uC, the medium was removed and replaced with
1 mL of fresh pre-warmed medium and the cells were returned to
37uC for 3.5 hours. Cells were then imaged using an Olympus
1671 microscope and Olympus MicroSuite Five imaging
software. For each well of the triplicate infections, five fields of
view were counted (100 cells/field of view) and the average
percentage of round cells was determined. The experiment was
performed in triplicate and repeated twice. Significance was
determined using one-way ANOVA with Tukey post-hoc test in
GraphPad.
Trimethoprim Assays
To evaluate the affect of trimethoprim on type III secretion,
secretion assays were performed in MM9. Bacteria were grown at
26uC for 2 hours and then at 37uC for 3 hours. 0, 15, or 30 mg/ml
of trimethoprim was added when the cultures were shifted to
37uC. Cells were sedimented and proteins in the pellet and
supernatant fractions were TCA precipitated and visualized by
immunoblotting. Because YP769 (KIM8 D1234) lacks all effector
Yops, we introduced the YopM expressing plasmid, pMM207, so
that we could track secretion of at least one effector. pMM207 was
constructed by amplifying a ,3.8 kb region containing YopM
using the primers YopM-upstream and YopM-downstream,
followed by cloning the blunt PCR product into the SmaI site of
pUC19. pMM207 was introduced into KIM8 and YP769 by
electroporation.
To assess the effect of trimethoprim on Yop injection, HeLa
cells (ATCC, CCL-2) were infected with Y. pestis strains carrying
pMM85 (YopE-Bla). Infections and microscopy were carried out
as previously described [44], except that trimethoprim (500 mg/
ml) was added during the infection.
Mouse infections
This study was carried out in accordance with the recommen-
dations in the Guide for the Care and Use of Laboratory Animals
of the National Institutes of Health. The work was approved by
the Institutional Animal Care and Use Committees at the
University of Chicago and Indiana University. All efforts were
made to minimize suffering of the mice.Y. pestis overnight cultures
were diluted 1:20 into HIB and grown for 3 hours at 26uC.
Cultures were washed and diluted to appropriate densities in PBS.
6–8 week old female BALB/c mice (Charles River Laboratories,
Inc., Wilmington MA or Harlan Laboratories, Indianapolis IN)
were anesthetized with either avertin (,400 mg/kg) or a cocktail
of ketamine (100–130 mg/kg) and xylazine (3–6 mg/kg) intra-
peritoneally. Mice were then injected via the retro-orbital plexus
with 0.1 ml suspensions of bacteria. The administered doses
consisted of serial dilutions from 10
0 to 10
5 cfu for KIM5 and 10
2
to 10
7 cfu for each mutant. All mice were monitored for signs of
disease for 14 days or until acute disease (hunched posture,
severely matted fur, emaciation, immobility) was apparent, at
which time mice were euthanized by CO2 inhalation followed by
cervical dislocation.
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Isolation of LCR
2 mutants
The design of the screen to identify chromosomal genes
involved in type III secretion of Yop proteins is shown in Figure 1.
The parent strain (KIM5) used in this study carries a functional
pla gene, which encodes a protease known to degrade fibrin clots
in vivo and is important for infection [46,47]. We chose to use this
strain, rather than a pla mutant, so that the transposon mutants
could be assayed in vivo as well as in vitro. Step 1 of the screen was
carried out similar to that of Goguen et al. [24]#. Y. pestis strain
KIM5 was mutagenized with Mucts62pAp5hP1#1, a Mu-P1
hybrid also called MuAphP1 [35]. This Mu derivative carries an
ampicillin resistance cassette to select for insertions of the
transposon into the Y. pestis genome. The pool of mutagenized
Y. pestis cells was then plated directly onto Blood Base agar
containing oxalate (a calcium chelator), and ampicillin to select
for mutants unable to undergo growth restriction (an LCR
2
phenotype) at elevated temperatures. We found a distribution of
insertions on pCD1 within the lcrA (yopN, tyeA, sycN, yscX, yscY,
lcrD/yscV, lcrR), lcrB (yscN-U), lcrC (yscA-L, lcrQ), virF, and virG/
yscW loci, demonstrating the validity of the screening process.
More importantly, mapping of the insertions by inverse PCR
showed that for the majority of chromosomal mutants identified
under these conditions there was only one insertion site,
indicating that the mutants harbored only a single Mu insertion
in the genome.
Screen for secretion defects
Transposon mutants that were able to grow under inducing
conditions (called CHI strains for chromosomal insertion) were
subjected to a secondary screen to analyze their ability to secrete
Yops in vitro (Step 2 in Figure 1). We first evaluated the ability of
the KIM5 parent to secrete Yops in various media over different
periods of time (data not shown). We chose to use a modified
version of M9 (MM9), a minimal medium previously shown to
induce secretion of Yops in Y. enterocolitica [48] because it gave the
highest level of Yop expression and secretion after three hours at
37uC. Characteristic patterns of degraded Yops were observed,
due to the Pla protease [49,50], and these patterns were consistent
during repeat experiments. After analyzing 2067 mutants showing
a growth phenotype in step 1 of the screen, we identified 1607
strains with decreased secretion, no secretion, or no expression of
YopE.
Locating transposon insertions
Genomic DNA from transposon mutants was used as template
for inverse PCR amplification of DNA regions surrounding the
Mu insertion. DNA sequences of amplified fragments were
subjected to BLAST analysis to locate the position of the insertion
(Step 3 in Figure 1). Out of 1607 candidates showing a defect in
secretion or expression of YopE, sequences were obtained for 1591
strains. In all but 290 strains, insertions on pCD1 were identified.
We were unable to determine the location of insertion for 16
strains. 13 strains harbored insertions in the 100-kb plasmid pMT1
and were not pursued further. The remaining 261 strains carried
at least one chromosomal Mu insertion.
To verify that the mutant phenotypes were not due to
unmarked spontaneous mutations on pCD1, which would not
have been identified by our sequencing analysis, we obtained a
pCD1 derivative in which the nptI cassette conferring kanamycin
resistance replaces the yopE-sycE locus [42]. This plasmid, which
we refer to here as pCD1::KM, was introduced into each of the
CHI strains carrying chromosomal insertions (Step 4 in Figure 1).
Candidates were screened for their ability to secrete YopM. The
replacement of the original pCD1 by the tagged pCD1::KM was
verified by immunoblotting to demonstrate the loss of yopE and the
presence of nptI (data not shown). Transposon mutants which
regained the ability to secrete YopM after acquiring the new
pCD1::KM were discarded. This final step of the screen identified
5 strains that carried a chromosomal insertion leading to a defect
in expression and/or secretion of Yops. Arrowheads in Figure 2
indicate the locations of the transposon insertions in these 5 CHI
strains. The mutants were next evaluated for their ability to secrete
Yops in vitro, inject Yops into mammalian cells, and cause disease
in a mouse model of infection.
Figure 1. Experimental strategy used to identify Y. pestis
chromosomal genes involved in type III secretion of Yops. In
Step 1, transposon mutants were selected based on their ability to grow
at 33uC in the absence of calcium. These mutants were subjected to a
secondary screen (Step 2) evaluating their ability to secrete Yops. All
mutants that displayed a defect in the synthesis or secretion of Yops
were then sequenced to identify the location of the Mu insertion (Step
3). To eliminate mutants that carried unmarked mutations on the
virulence plasmid, the tagged pCD1::KM was used to displace the
original pCD1, and the transformants were then evaluated for their
ability to secrete Yops (Step 4). Strains which retained the secretion
defect after Step 4 were kept for further characterization.
doi:10.1371/journal.pone.0034039.g001
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To characterize each of the transposon mutants, secretion
assays were conducted using minimal (MM9) and rich laboratory
media (HIB with or without EGTA) (Figure 3 and data not
shown). RpoA, which is the alpha-subunit of RNA polymerase,
was used a fractionation and loading control, since its expression
should be independent of the TTSS and it remains in the bacterial
cytoplasm. YscD is a TTSS machine component, which is also not
secreted and should only be visible in the cell pellets. To evaluate
Yop secretion, we used antibodies against the effectors YopM and
YopE. A transposon mutant carrying an insertion in the TTSS
component yscU, which was isolated from this screen, was included
as a negative control. As expected, this mutant did not secrete
Yops and displayed lower levels of TTSS proteins. Interestingly,
one of the chromosomal mutants displayed a conditional
phenotype depending on the medium used in the assay. CHI
1345 (ctgA
2) consistently secreted less Yops than the KIM5 parent
strain when grown in MM9 (Figure 3). However, in HIB there was
a clear absence of Yops in the culture supernatant for the mutant,
in addition to decreased expression of TTSS proteins (not shown).
The secretion phenotypes of the remaining CHI strains were
consistent in both types of media: they did not secrete YopE or
YopM in either MM9 or HIB lacking calcium (Figure 3 and data
not shown). Similar to the yscU mutant, the chromosomal mutants
all had lower expression levels of TTSS related proteins, although
to varying degrees. The lack of Yop secretion in these mutants
therefore may be due to impaired TTSS expression. When
plasmids carrying the respective wild type genes were introduced
into each mutant, expression and secretion of Yops was restored,
thereby confirming that the mutant phenotypes are the result of
the transposon insertions (Figure 3).
Targeting phenotypes of CHI strains
The purpose of the Yersinia TTSS is to inject effector Yops into
target host cells during infection. To determine if any of the
transposon insertions identified in our screen contribute to this
aspect of virulence, we analyzed the fate of two injected effector
Yops (YopE and YopM) during infection of tissue culture cells. We
introduced plasmids bearing b-lactamase fusions to YopM
(pMM83), YopE (pMM85), or glutathione-S-transferase (Gst,
pMM91) [44] into the CHI strains and the KIM5 parent
(Figure 4). These strains were used to infect CHO cells at an
MOI of 10 for three hours. CCF2-AM, a fluorescent substrate for
b-lactamase, was added to stain CHO cells prior to flow
cytometry. Cells that had not been injected with b-lactamase
hybrids fluoresce green as a result of fluorescence resonance
energy transfer (FRET) within intact (uncleaved) CCF2-AM
substrate. In the presence of b-lactamase, however, FRET is
disrupted, resulting in blue fluorescence of cells that are injected
with hybrid Yop-Bla fusions via the Yersinia type III pathway. The
levels of fluorescence in each cell can be quantified by flow
cytometry, and when synchronized, infections by different strains
can be quantitatively compared [44,45]. As previously demon-
strated [44,45], an abundance of blue cells were observed when
KIM5 carrying either pMM83 (YopM-Bla) or pMM85 (YopE-
Bla), but not pMM91 (Gst-Bla), was used to infect CHO cells
(Figure 4 A and B and data not shown). Also as previously
demonstrated, the yscU
2 mutant did not translocate YopM-Bla or
YopE-Bla (data not shown). pgsA
2 had an identical phenotype to
yscU
2 in that it also did not inject either Yop-Bla reporter into host
cells. Surprisingly, rfaL
2 injected both Bla reporters at wild type
levels. In addition, the remaining mutants all injected YopM-Bla
and YopE-Bla, albeit at significantly lower levels than wild type
(*** P,0.001).
To confirm the translocation phenotypes of the mutants we also
evaluated the ability of each mutant to cause cytotoxicity
associated with Yop delivery. Toward that end, HeLa cells were
infected with Y. pestis strains for 3–4 hours and then visualized by
microscopy to determine the percentage of cell rounding. As
shown in Figure 4C, the majority of cells infected with KIM5 were
round, while cells infected with yscU
2 appeared similar to
uninfected cells. Likewise, cells infected with folD
2, pgsA
2, and
pssA
2 all showed no significant difference compared to uninfected
cells. The ctgA mutant was still able to cause some cytotoxicity,
though the percentage of cell rounding was still lower than WT
(P,0.001). In contrast, the rfaL mutant behaved identically to WT.
These data correlate nicely with the Bla reporter assays and
confirm that the rfaL mutant is able to deliver Yops as well as WT,
whereas Yop injection by the remaining mutants is impaired.
Heterologous expression cannot bypass the mutant
defects
Since several mutants displayed defective expression of TTSS
proteins, and since the defect in secretion could be bypassed by cell
contact in some cases to allow Yop injection during cell culture
infection, we hypothesized that there may be conditional blocks in
the TTSS at the level of expression. To determine if heterologous
expression of a Yop could bypass the defects observed in the
mutants, we introduced a plasmid carrying a yopM-bla fusion
located behind the constitutive nptII promoter. As previously
demonstrated for other Yop fusions under the control of the this
promoter [51]#, expression of YopM-Bla was considerably lower
than from the native yopM promoter (Figure 5). Despite the low
level of expression, YopM-Bla and its characteristic degradation
products were routinely detected in the supernatant of wild type
secretion assays (Figure 5). For the CHI strains, all of them
Figure 2. Identification of mutations in CHI strains. The genetic
locus carrying the Mu insertion, indicated by an arrowhead, is depicted
for each CHI strain. The genome annotations of the disrupted genes
(shaded) are shown. Arrows refer to primer locations used to amplify
and clone each locus for complementation analysis. Expression of folD
and pssA were driven by the nptII promoter.
doi:10.1371/journal.pone.0034039.g002
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reporter did not appear in culture supernatants (Figure 5). It
remains a formal possibility that low levels of Yops or YopM-Bla
are secreted in these mutants, which are undetected due to Pla
activity; however, after repeated attempts to observe secretion at
various times after induction of the TTSS, we never observed
YopM-Bla or any apparent degradation products of the reporter
in the culture supernatants. This lack of secretion, despite high
expression levels of the reporter, supports the conclusion that Yop
secretion is impaired in these mutants. Therefore, it is unlikely that
the absence of Yops in the supernatants during secretion assays
(Figure 3 and 5) is simply due to detection limits of the assay or a
result of impaired Yop expression. The defects may however be
attributed to decreased expression of the TTSS machine
components, at least in the cases of folD
2, pgsA
2, and pssA
2
(Figure 5), as these mutants display less YscD and YscF.
It is important to point out that while some Yops could be
detected in the supernatant of pgsA
2 (Figure 5), the cytoplasmic
protein RpoA, which is used as a fractionation control, was also
found in the supernatant. In contrast, the majority of Ail (an outer
membrane protein and additional fractionation control) was found
in the cell pellet fraction, as expected. This was a consistent
observation, even after filtering supernatants to ensure removal of
cells, suggesting that these mutant cells may be leaky (Figure 3 and
data not shown). Therefore, we cannot determine from these
experiments whether the small amount of Yops occasionally seen
in the supernatant for this mutant is due to type III secretion or
simple leakage.
Since cell contact was able to bypass the in vitro secretion defect
for some mutants, we tested whether heterologous expression of
the YopM-Bla reporter could restore injection levels to that of wild
type for the transposon mutants. As expected, constitutive
expression of YopM-Bla resulted in high levels of its injection
into CHO cells by the parent strain (Figure 6). Again, rfaL
2
displayed a similar ability to inject the YopM-Bla reporter. In fact,
there was no significant difference in Bla reporter injection
between wild type and rfaL
2 during any of the translocation assays
(Figures 4 and 6). Both strains showed a statistically significant
increase (diamonds: P,0.001) in YopM-Bla injection when the
reporter was constitutively expressed (compare Figure 4A to
Figure 6). Likewise, although injection of YopM-Bla by ctgA
2 was
still impaired (*** P,0.001) compared to wild type (Figure 6),
constitutively expressing the reporter did significantly enhance its
injection (Figure 4A and 6). In contrast, folD
2, pgsA
2, and pssA
2
did not respond to heterologous expression of the reporter. Both
folD
2 and pssA
2 translocated similar amounts of the YopM-Bla
reporter whether expression was driven from the native promoter
or the npt promoter, and pgsA
2 did not translocate any YopM-Bla.
Role of folate synthesis on type III secretion
One of the mutants, CHI 919 (folD
2), was unable to secrete
Yops in vitro and was only able to inject low levels of Yops into
tissue culture cells (Figures 3,4,5,6). To determine whether the
effect of the Mu insertion in CHI 919 on type III secretion was
specific to the folD gene, or if it was reflective of folate biosysnthesis
in general, we tested whether trimethoprim, a dihydrofolate
reductase (DHFR) inhibitor, also inhibits injection of Yops by the
TTSS (Figure 7). When the wild type strain KIM5 was incubated
for three hours with trimethoprim, bacterial growth was inhibited,
but the cells were still viable throughout the duration of the
experiment (data not shown). We then infected HeLa cells with
KIM5 carrying pMM85 (YopE-Bla), in the presence or absence of
trimethoprim, for three hours. Because of the growth inhibition
that was observed in the presence of drug, we used an MOI of 1
and 10 for the KIM5 infections. As a negative control, HeLa cells
were also infected at an MOI of 10 with the TTSS mutant (yscQ
2)
expressing YopE-Bla. After the infections, cells were stained with
CCF2-AM and visualized by microscopy to evaluate injection of
the Bla reporter. In the absence of drug at an MOI of 10, large
numbers of bacteria could be seen, and most of the HeLa cells
displayed blue fluorescence indicating translocation of the YopE-
Bla reporter (Figure 7A). When the MOI was decreased to 1, in
the absence of drug, there was a mixture of green and light blue
cells indicating that the YopE-Bla reporter was injected into host
cells to a lesser extent. In contrast, when trimethoprim was added,
no blue cells were observed, even at an MOI of 10, which gave a
Figure 3. Secretion phenotypes of CHI strains. Complementation plasmids were introduced into each mutant and the KIM5 parent, and the
strains were evaluated by performing secretion assays. The TTSS mutant, yscU, was included as a negative control. Y. pestis strains were grown in
MM9 at 26uC for 2 hours and then shifted to 37uC for 3 hours to induce secretion. Proteins in the supernatant (S) and pellet (P) fractions were
precipitated and visualized by immunoblotting with antibodies to YopM, YopE (TTSS secreted proteins), YscD (TTSS apparatus component) and RpoA
(RNA Polymerase alpha subunit, loading and fractionation control). An asterisk indicates truncated Yops due to degradation by Pla protease.
doi:10.1371/journal.pone.0034039.g003
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of drug (Figure 7A). Likewise, cells that were either uninfected or
infected with the yscQ
2 mutant did not turn blue, confirming that
the appearance of blue cells correlates with delivery of YopE-Bla
in a TTSS dependent manner. Because no injection of YopE-Bla
was observed for cells treated with trimethoprim, we hypothesized
that trimethoprim may prevent expression and/or function of the
TTSS.
To further assess the effects of trimethoprim on the TTSS, we
conducted secretion assays in MM9 in the presence or absence of
trimethoprim (0, 15, 30 mg/ml). For these experiments, KIM8
(pla
2) was used as the parent strain to ensure that the absence of
secreted Yops is not due to degradation by the Pla protease. We
also used Y. pestis strain KIM8 D1234 [37], which carries a
dihydrofolate reductase cassette conferring trimethoprim resis-
tance, thereby allowing us to assess any non-specific effects of the
drug on protein expression.
This strain lacks all the effector Yops (DyopM/yopT/sycT/yopK/
ylpA/yopE/sycE/ypkA/yopJ/yopH), so we introduced a plasmid
carrying the yopM locus into both KIM8 and KIM8 D1234. This
allowed us to track expression and secretion of YopM, as well as
YopN, YopR, and YopD, which are still present in KIM8 D1234.
We also tracked expression of two non-TTSS proteins: Ail, which
is an outer membrane protein adhesin that is constitutively
expressed [52,53], and RpoA As shown in Figure 7B, expression of
TTSS proteins (YopM, YopN, YopR, YopD) was severely reduced
after addition of the drug to the KIM8 parent. Not surprisingly,
secretion of those proteins was also severely reduced (at 15 mg/ml)
or abolished (at 30 mg/ml) of trimethoprim. However, expression
of unrelated, non-TTSS proteins (Ail and RpoA) was only slightly
reduced in the presence of the drug. In contrast to KIM8,
expression and secretion of all proteins by KIM8 D1234 was
unaffected even at the highest concentration of trimethoprim
(Figure 7B).
Since expression of non-TTSS proteins was less affected by
trimethoprim treatment, we asked whether heterologous expres-
sion of a Yop could overcome the affects of trimethoprim. We
therefore introduced pAH83, which expresses YopM-Bla from the
nptII promoter, into KIM8 and performed secretion assays as
before. As shown in Figure 7C, expression of YopM-Bla from the
nptII promoter was also only slightly reduced, even at the highest
trimethoprim concentration. However, despite being expressed,
YopM-Bla was not secreted in the presence of trimethoprim,
which is probably due to the lack of TTSS proteins. These
observations suggest that availability of folate contributes to the
regulation of type III secretion in Y. pestis and may be reflective of
a link between the TTSS and the metabolic state of yersiniae.
Furthermore, since type III proteins were either absent or barely
visible within the pellet fractions, it suggests that the effect of a
block in the DHFR pathway is at the level of expression of genes in
the type III pathway.
Independent mechanisms for activating the TTSS
One of the transposon mutants, CHI 1800 (rfaL
2), despite
having a secretion defect in vitro (Figures 3 and 5), was able to inject
Yops like wild type during infection of CHO cells (Figures 4 and
6). The ability of rfaL
2 to inject Yops as well as the parent was
independently verified using HeLa cells, followed by digitonin
fractionation of infected cells and immunoblotting (data not
shown). The finding that the rfaL
2 mutant is able to deliver Yops
Figure 4. Translocation phenotypes of CHI strains. CHO cells
were infected with Y. pestis strains carrying either pMM83 (YopM-Bla,
Panel A), pMM85 (YopE-Bla, Panel B) or pMM91 (Gst-Bla, not shown) at
37uC for 3 hours, followed by CCF2-AM staining and flow cytometry to
quantify blue and green fluorescence. The level of translocated Bla
reporter is indicated by white (no injection, green fluorescence), gray
(intermediate level of injection, aqua fluorescence), or black (high level
of injection, blue fluorescence) bars. For each experiment, the assays
were performed in triplicate, and error bars indicate the standard
deviation. The data shown is representative of three independent
experiments. One-way ANOVA with Tukey post-hoc test was done to
demonstrate significant differences in injection (high-level injection,
black bars) for mutants relative to the wild type parent. *** P,0.001. To
assess cytotoxicity due to Yop delivery, cell rounding was also
evaluated (Panel C). HeLa cells were infected with the indicated Y.
pestis strains for 3–4 hours. The percentage of round cells was
determined for each infection. The infections were performed in
triplicate and error bars represent standard deviation. The data shown is
representative of two independent experiments. One-way ANOVA with
Tukey post-hoc test was done to determine significance. *** Represents
significant difference of mutants compared to WT (P,0.001); n.s.=no
significance between indicated strains.
doi:10.1371/journal.pone.0034039.g004
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absence of calcium in vitro. To determine whether the disparity in
observed phenotypes could be attributed to the different growth
media used in the assays, we conducted in vitro secretion assays in
the same medium used to culture HeLa cells (DMEM
supplemented with FBS and glutamax). As observed in Figure 8,
the mutant was able to both express and secrete the early Yops
YopR, YopD, and LcrV as well as wild type when grown in
DMEM containing calcium. As expected the late Yops YopE,
YopH, and YopM were not secreted in the presence of calcium
by either wild type or mutant. However, when EGTA was added
to chelate the calcium, YopE, YopH, and YopM were all secreted
by wild type KIM5 (Figure 8). In contrast, when calcium was
chelated from the medium, rfaL
2 did not secrete either early or
late Yops. The mutant expressed all Yops in the absence of
calcium, but several of the Yops appear to be synthesized at lower
levels in the mutant compared to wild type (see pellet fractions of
YopR, YopD, LcrV, YopE). In addition, the level of the TTSS
component YscD is also reduced in the mutant in the absence of
calcium (Figure S1). As expected the defects in expression and
secretion are restored by complementing the mutant in trans
(Figure S1). Since the expression levels of Yops and the TTSS
machine are reduced when calcium is depleted, it is possible that
the absence of calcium prevents the proper function of assembled
needles in rfaL
2, leading to the negative feedback on TTSS
expression that is typically seen for mutations within TTSS
components. The data suggest that although the secretion
apparatus in the rfaL mutant is capable of transporting early
Yops, it cannot respond normally to the low calcium signal in
order to fully activate the TTSS to secrete the effector (late) Yops,
and this signaling defect can be overcome during cell contact.
Thus, it appears that, while the type III pathway can be induced
by either chelating calcium in vitro or by cell contact in vivo, Y.
pestis can discern and respond to these two stimuli by different
mechanisms.
Figure 5. Secretion phenotypes of strains carrying a heterologously expressed Yop reporter. pAH83, which constitutively expresses
YopM-Bla, was introduced into each mutant and the KIM5 parent, and the strains were evaluated by performing secretion assays as described in
Figure 3. Proteins were visualized by immunoblotting with antibodies to b-lactamase (YopM-Bla), YopM, YopE (TTSS secreted proteins), YscD, YscF
(TTSS apparatus components) Ail (outer membrane protein) and RpoA (cytoplasmic protein, loading and fractionation control). An asterisk indicates
truncated Yops due to degradation by Pla protease.
doi:10.1371/journal.pone.0034039.g005
Figure 6. Translocation phenotypes of strains carrying a
heterologously expressed Yop reporter. CHO cells were infected
with Y. pestis strains carrying pAH83 at 37uC for 3 hours, followed by
CCF2-AM staining and flow cytometry. Cells were analyzed for blue and
green fluorescence. The level of translocated Bla reporter is indicated by
white (none), gray (intermediate level), or black (high level) bars. For
each experiment, the assays were performed in triplicate, and error bars
indicate the standard deviation. The data shown is representative of
three independent experiments. One-way ANOVA with Tukey post-hoc
test was done to demonstrate significant differences in injection (high-
level injection, black bars) for mutants relative to the wild type parent.
*** P,0.001. Diamonds indicate statistically significant differences
(P,0.001) compared to samples in Figure 4, Panel A.
doi:10.1371/journal.pone.0034039.g006
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The Yersinia TTSS is an essential virulence component, and
mutants lacking a functional TTSS are unable to cause acute
disease in mouse models of infection. Therefore, we next
investigated the ability of the chromosomal mutants to cause
disease in mice. BALB/c mice were infected intravenously with
the KIM5 parent or its isogenic mutant CHI strains. Doses were
administered in 10-fold increments spanning from 10
0 to 10
5 cfu
for wild type and from 10
2 to 10
7 for the mutants in order to
determine the AD50 (dose required to cause acute disease in 50%
of the population). The results are summarized in Table 1. As
expected, wild type KIM5 produced signs of disease in a dose
dependent manner. For mice infected with the highest dose
(10
5 cfu) visible symptoms, such as ruffled fur and squinty eyes,
were apparent on day 1. The disease progressed normally and by
days 5–6 signs of terminal disease were apparent (severely matted
fur and partially or completely closed eyes, severe weight loss, rigid
hunched posture, lack of mobility even when touched, labored
breathing), at which point the mice were judged to be moribund
and were euthanized. The AD50 for the parent was determined to
be between 800–3400 cfu in three independent experiments. In
contrast, all mutants were reduced in virulence by several orders of
magnitude. Infections at the highest dose of 10
7 cfu with folD
2,
pgsA
2, and pssA
2 all resulted in the appearance of ruffled fur for 2
to 3 days post-infection, indicating illness relating to the high doses
of Gram-negative bacteria. However by days 5 to 6, the symptoms
Figure 7. Trimethoprim inhibits the Yersinia TTSS. A. HeLa cells
were infected with KIM5 or CHI 30 (yscQ
2) expressing YopE-Bla.
Infections were carried out at the indicated MOI for three hours in the
presence or absence of 500 mg/ml of trimethoprim. Following infection,
cells were stained with CCF2-AM and visualized by microscopy to assess
translocation of the YopE-Bla reporter. Blue fluorescence=YopE-Bla
injection; green fluorescence=no injection. B. Y. pestis KIM8 and KIM8
D1234, carrying pMM207 (yopM expressed from native promoter), were
subcultured into MM9 and grown at 26uC for 2 hours. Trimethoprim
was then added at the indicated concentrations (0, 15, or 30 mg/ml) and
the cultures were shifted to 37uC for 3 hours, followed by TCA
precipitation of supernatant (S) and cell pellet (P) fractions and
immunoblotting with antibodies against YopM, YopN, YopD, YopR
(TTSS secreted proteins), YscD (TTSS machine), RpoA (cytoplasmic
protein), Ail (outer membrane protein). Degradation products are not
indicated since KIM8 and KIM8 D1234 lack Pla protease. C. Secretion
assays and western blotting was performed as in Panel B using Y. pestis
KIM8 carrying pAH83 (yopM expressed from nptII promoter).
doi:10.1371/journal.pone.0034039.g007
Figure 8. CHI 1800 cannot induce type III secretion in response
to low calcium. Y. pestis strains KIM5 and CHI 1800 (rfaL
2) were
subcultured into DMEM with or without EGTA and grown at 26uC for
2 hours and 37uC for 3 hours, followed by TCA precipitation of
supernatant and cell pellet fractions and immunoblotting for early
Yops (YopR, YopD, LcrV) and late Yops (YopH, YopM, YopE).
doi:10.1371/journal.pone.0034039.g008
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ever moribund and no deaths occurred at these doses or any of the
lower doses for infections with any of these mutants. Identical
results were obtained using the yscQ TTSS mutant isolated from
this screen. These results demonstrate that these three mutants are
indeed avirulent.
In contrast, ctgA
2 and rfaL
2 were extremely attenuated but did
retain some ability to cause disease at the highest doses tested. Five
out of five mice infected with 10
7 cfu of ctgA
2 became moribund
and were euthanized by days 4 to 7. All mice infected with lower
doses of ctgA
2 survived. From this, we estimate an AD50 of
,4610
6 cfu. Similarly, all mice infected with 10
7 cfu of rfaL
2
became ill, but only 3 of 5 mice progressed to moribundity and
were euthanized 5–7 days post-infection. Mice infected with lower
doses of rfaL
2 did not become ill. From this, we estimate that the
AD50 is equal to or greater than 10
7 cfu. Because it is not possible
to test higher doses, we can only estimate an AD50 for these two
mutants and therefore cannot determine whether there is
statistically significant difference in virulence between them.
However when the data is evaluated to determine time to death,
there does not appear to be any significant difference. Figure 9
shows the survival curves for mice infected with 10
5 cfu of WT,
10
5 or 10
7 cfu of ctgA
2, and 10
5 or 10
7 cfu of rfaL
2. The median
survival time was 5.5 days for mice infected with WT, compared to
7 days for mice infected with either mutant at the 10
7 cfu dose.
The Log-rank test was used to compare the survival curves
between WT and the two mutants. There was no significant
difference between the two mutants, indicating that they are
similarly attenuated (P=0.2725). When each mutant (10
7 cfu) was
compared to WT (10
5 cfu), there was also no significant difference
(P=0.0629 for ctgA
2 and P=0.0361 for rfaL
2), which indicates
that at the highest doses tested the mutants resemble WT in their
ability to cause terminal disease. Thus, while ctgA
2 and rfaL
2
display severely attenuated phenotypes in this mouse model of
infection, these strains are not completely avirulent and retain
some ability to cause lethal disease in mice.
Discussion
The Yersinia TTSS is an essential component of virulence, and
loss of the TTSS, either by mutational inactivation or loss of the
pCD1 virulence plasmid, corresponds with a reduction in
virulence by six orders of magnitude or more [54]#. Therefore,
the TTSS represents an important target for vaccine and
therapeutic approaches. Previous work alluded to the presence
of chromosomal loci, which contribute to the regulation of type III
secretion of Yops by Yersinia pestis [24]. However these genes have
remained unidentified. We sought to identify these chromosomal
loci as they represent potential targets for vaccine development.
CHI 1065 (pgsA) and CHI 1965 (pssA)
After screening over 2000 strains carrying transposon insertions
and displaying the LCR
2 growth phenotype, we identified five
mutants that displayed a strong defect in type III secretion. Three
of those mutants (CHI 1065, 1800, 1965) carried insertions in
genes involved in the biosynthesis or integrity of the cell envelope.
CHI 1065 carries an insertion in pgsA, which encodes a
phosphatidylglycerophosphate synthase. Phosphatidylglycerol
(PG) is an essential component of membranes, and E. coli mutants
lacking pgsA are not viable [55]. While it appears that pgsA is not an
essential gene in Y. pestis, CHI 1065 does have a growth defect as
shown by a ,20% longer doubling time compared to wild type
(Table 1). PG is essential for lipid modification and the proper
localization and/or function of proteins such as DnaA and SecA.
It is also a precursor for membrane-derived-oligosaccharides
(MDO’s), which serve as an osmoprotectant. In Y. enterocolitica, the
lipoprotein VirG [56] is required for the proper localization of the
YscC secretin in the outer membrane [57]. The lipid modification
of VirG is essential for its interaction with YscC and is therefore
necessary for type III secretion of Yops [58]. Because of the
involvement of PG in localization of membrane proteins, and its
requirement for the Sec-dependent translocation pathway, it is
likely that the effect of the pgsA mutation in Y. pestis is pleiotropic.
Further work is necessary to determine if components of the type
III secretion machinery, as well as other membrane proteins which
Table 1. Mutant phenotypes.
Strain Mutation Doubling time (hours)
a AD50 Median survival
b
KIM5 WT 1.34 (0.03) 800–3400 cfu 5.5 days
CHI 919 folD 1.95 (0.01) .10
7 cfu ND
CHI 1065 pgsA 1.60 (0.03) .10
7 cfu ND
CHI 1345 y0447 (ctgA) 1.31 (0.02) 4610
6 cfu 7 days
CHI 1800 y3762 (rfaL) 1.28 (0.09) =10
7 cfu 7 days
CHI 1965 pssA 1.62 (0.03) .10
7 cfu ND
aIn vitro growth curves were done using Heart Infusion Broth.
bMedian survival was calculated based on infections with WT at 10
5 cfu, the ctgA mutant at 10
7 cfu, or the rfaL mutant at 10
7 cfu. No deaths occurred during infections
with other mutants, so survival times are not indicated (ND).
doi:10.1371/journal.pone.0034039.t001
Figure 9. In vivo attenuation of CHI strains. BALB/c mice were
infected intravenously with serial dilutions Y. pestis KIM5 or transposon
mutants. Moribund mice were euthanized and time to death was
recorded. Survival curves are shown for KIM5 (WT) and two mutants
(ctgA
2 and rfaL
2).
doi:10.1371/journal.pone.0034039.g009
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CHI 1065.
Likewise, the pssA mutation in CHI 1965 may affect membrane
structure or localization of membrane proteins. pssA is required for
the synthesis of phosphatidylserine (PS) and subsequently phos-
phatidylethanolamine (PE), which comprises 70–80% of mem-
brane phospholipids [55]. PE constituents also decorate MDO’s
and LPS, thereby potentially contributing to membrane structure
and integrity. As in the case of pgsA
2, the loss of pssA function is
not a lethal event, but it does result in approximately 20% longer
doubling time in vitro (Table 1).
CHI 1800 (y3762 or rfaL)
Surprisingly, in CHI 1800 we identified an insertion in a gene
predicted to be involved in LPS biosynthesis (y3762). Although Y.
pestis harbors several mutations in the O Antigen biosynthetic
cluster [59,60], it does produce a lipo-oligosaccharide (LOS) with
pyrogenic properties [61]#. The core component of Y. pestis LOS
is based on a pentasaccharide containing 4 heptose residues
attached to lipid A via Kdo [62]. CHI 1800 carries an insertion in
y3762. Although there were no BLAST hits with any significant
homology, y3762 is annotated as a putative lipid A-O Antigen
ligase. Further comparison of Y3762 and RfaL (the corresponding
protein in E. coli [63]#) reveals that both of these proteins are
largely transmembrane and the largest contiguous periplasmic
stretch of the proteins contain the O-antigen polymerase domain.
Moreover, y3762 is located in a predicted operon with rfaQ, which
is involved in completion of the inner core of LPS in E. coli.
Therefore, we propose to refer to y3762 as rfaL.
The lack of O Antigen in Y. pestis makes the physiological
function of RfaL unclear. Interestingly, in E. coli RfaL is also
involved in the transfer of alternative saccharides, including
enterobacterial common antigen (ECA), to the LPS core [64,65].
The Y. pestis genome carries the genes for ECA biosynthesis, and
several mutations in that pathway were isolated in our screen that
lead to only a slight decrease in Yop secretion (unpublished
observations). Therefore RfaL may be required for the attachment
of an unidentified saccharide moiety to the LOS core.
Low calcium response versus cell contact
Interestingly, rfaL
2 exhibited the ability to distinguish between
activation of the type III pathway in response to low calcium
versus cell contact. A similar phenotype was observed in
Pseudomonas aeruginosa, where it was found that there are two
independent pathways for inducing expression of TTSS genes
[66]#. These observations suggest that although a low calcium
environment can trigger secretion, it is not a mimic of cell contact.
Additionally, our results indicate that there are different
mechanisms for activation of the secretion machinery in Y. pestis.
It is possible that chelating environmental calcium induces a
conformational change in the secretion apparatus, thereby
allowing secretion substrates to pass. In the context of a cell
culture infection, where there is calcium present in the medium,
protein-protein interactions during cell contact could also lead to a
conformational change leading to secretion of TTSS effectors.
Further work is required to determine how the conformational
change in the secretion apparatus is sensed and which proteins are
involved in the hypothetical protein-protein interaction during
target cell contact.
CHI 1345 (y0447 or ctgA)
One of the mutants, CHI 1345, isolated in this screen carried a
mutation in a hypothetical gene. Y0447 is predicted to have 4
transmembrane helical domains and localize to the cytoplasmic
face of the membrane. It is annotated as belonging to the DedA
family of membrane proteins. Proteins from this family can be
found in members of the a-, b-, and c- proteobacteria. Little is
known about the function of the proteins, and these proteins often
share little similarity in their amino acid sequences. However,
screens performed in E. coli, Salmonella, and Neisseria have shown
that proteins in the DedA family are associated with cell division,
response to divalent cations, and resistance to cationic antimicro-
bial peptides, all of which are linked to membrane biology
[67,68,69]. The phenotypes of the mutants isolated in these
screens suggest that they may have structural defects in their
membranes. Mutations in genes encoding YghB and YqjA of the
DedA family in E. coli result in an altered phospholipid ratio in the
membranes of the mutants [67]. Interestingly, CHI 1965 (pssA
2)
and CHI 1065 (pgsA
2) isolated from our screen would also be
predicted to have altered phospholipid ratios. We suspect that
y0447, pgsA and pssA may play a role in maintaining the structure
and stability of the bacterial membranes. Defects in membrane
biology in these mutants could consequently affect the structure or
stability of the TTSS machinery. It is not clear at this point if any
such membrane defect would prevent the proper assembly of the
TTSS machinery or if these alterations would activate cellular
stress response systems that could lead to a regulatory block on
expression of the TTSS genes. Because this is the first
characterization of y0447, we will refer to it as ctgA (chromosomal
type III secretion gene), for its role in type III secretion.
CHI 919 (folD)
In contrast to several other screen isolates with mutations
affecting membrane structure, the transposon insertion in folD in
CHI 919 likely causes an effect on metabolic functions. folD is
annotated as a bifunctional enzyme (5, 10-methylene-tetrahydro-
folate dehydrogenase and cyclohydrolase) similar to that of E. coli
[70]# which is involved in tetrahydrofolate (THF) production.
The Y. pestis genome harbors two additional genes, glyA and gcvT,
whose products are predicted to bypass the FolD-catalyzed
reactions, thus explaining the viability of CHI 919 in media
lacking folate. Despite this, CHI 919 had the most severe growth
defect of the mutants with a ,65% longer doubling time (Table 1).
THF is an important coenzyme and provides one-carbon donors
to several metabolic pathways including purine, methionine and
thymidylate synthesis [71]. The observation that trimethoprim
inhibits type III secretion (Figure 7), likely at the level of
expression, confirms the importance of folD and/or THF in type
III secretion. Therefore, the lack of secretion in a folD mutant
(CHI 919) may reflect a connection between type III secretion and
the metabolic state of the cell. This hypothesis is supported by
studies in Pseudomonas aeruginosa, which showed that histidine levels
and the two-component system, cbrAB, contribute to the regulation
of type III secretion [72]. Similarly, the aceAB operon, which
encode subunits of pyruvate dehyrogenase, are also necessary for
type III secretion in P. aeruginosa [73].
Perspectives
In conclusion, Y. pestis genes identified in a Mu insertional
mutagenesis screen for LCR phenotypes point to hitherto
unappreciated roles for LPS biosynthesis, envelope structure and
integrity, and intermediary metabolism in the Yersinia TTSS.
Further, unknown genes that have never been linked to type III
secretion may reveal novel regulatory or assembly mechanisms for
the type III pathway. Several other genetic screens using STM or
IVET to identify virulence genes have been conducted in Yersinia
species [74,75,76,77,78], yet there is no overlap between the genes
identified previously and those identified in our study. One
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presumably there are additional chromosomal genes that may
contribute to type III secretion. Additionally, the STM and IVET
screens are used to identify genes that are important in vivo, and the
approaches are fundamentally different than ours. It is interesting
to note that all of the mutants tested in our screen demonstrated a
clear virulence defect. Perhaps a more thorough STM screen in Y.
pestis would also identify these or similar genes. In P. aeruginosa,
several screens have identified environmental sensors and two-
component systems, such as soxR, copRS, and retS, as important
regulatory factors [79,80,81,82]. Although we did not identify any
of those genes in this study, it is not unlikely that similar signal
transduction cascades exist in Yersinia species, and this is a prospect
that warrants further investigation.
Finally, as one goal of our screen was to identify candidates for
vaccines or new antimicrobials, we must point out the affect of
trimethoprim on the TTSS (Figure 7). Trimethoprim, which is
among the treatment options for plague infections, targets FolD.
And while the antimicrobial properties of trimethoprim are
independent of its affect on the Yersinia TTSS, the isolation of a
folD mutant (CHI 919) in our screen along with the observation
that trimethoprim prevents proper expression of TTSS compo-
nents, may indicate an additional indirect method for the drug to
inhibit disease progression. It is possible that other genes identified
by this study would also make good targets for antimicrobials. A
particularly interesting possibility for a broad-spectrum target is
CtgA, which appears to be widely conserved. Since loss of CtgA
impairs TTSS without affecting growth, targeting it may be useful
in reducing virulence without putting a direct selective pressure on
growth and correspondingly on the selection of drug-resistant
mutants.
Supporting Information
Figure S1 Secretion phenotype of CHI 1800. Y. pestis
strains KIM5 and CHI 1800 (rfaL
2), in the presence or absence of
complementing plasmid, were subcultured into DMEM with or
without EGTA and grown at 26uC for 2 hours and 37uC for
3 hours, followed by TCA precipitation of supernatant and cell
pellet fractions and immunoblotting for YopE and YscD
(TIF)
Table S1 Primers used in this study.
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